Transthyretin (TTR) was shown to be dysregulated in ALS compared to control spinal cord samples [60] and Beta 2-microglobulin (B2M) has shown differential RNA expression in the peripheral white blood cells of ALS patients compared to control [61], making them potential biomarkers. This evidence concerns the gene B2M and amyotrophic lateral sclerosis.